Diagnostic performance of 99mTc-PSMA SPECT/CT in primary prostate carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-3)

Sum=15

Aug 26, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Cases. Aug 26, 2025; 13(24): 107555
Published online Aug 26, 2025. doi: 10.12998/wjcc.v13.i24.107555

Table 2 Mean values of semi-quantitative parameters (count ratios) in benign and malignant groups

Parameter	mean ± SD in benign group (n = 9)	mean ± SD in malignant group (n = 20)	P value
Prostate:background count ratio	6.65 ± 5.17	37.18 ± 48.85	0.004
Prostate:liver count ratio	1.14 ± 0.56	5.35 ± 7.35	0.023

P value < 0.05 is statistically significant.

Citation: Agrawal K, Patro PSS, Singhal T, Satpati D, Nayak P, Mandal S, Kumar N, Padhy BM, Sable M, Meher BR. Diagnostic performance of ^99mTc-PSMA SPECT/CT in primary prostate carcinoma. World J Clin Cases 2025; 13(24): 107555
URL: https://www.wjgnet.com/2307-8960/full/v13/i24/107555.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i24.107555